NEWS
CONTENTS
CONTACTOSAKA
HEAD OFFICE

DAIWA MINAMIMORIMACHI BLDG.,
2-6, 2-CHOME-KITA, TENJINBASHI,
KITA-KU,OSAKA 530-0041 JAPAN
TEL:+81-6-6351-4384
(Main Number)
FAX:+81-6-6351-5664
(Main Number)
E-Mail:

TOKYO
HEAD OFFICE

WORLD TRADE CENTER BLDG. 21F,
2-4-1, HAMAMATSU- CHO, MINATO-KU,
TOKYO 105-6121,JAPAN
TEL:+81-3-3433-5810
(Main Number)
FAX:+81-3-3433-5281
E-Mail:


HIROSHIMA
OFFICE

NOMURA REAL ESTATE HIROSHIMA BLDG. 4F, 2-23 TATEMACHI, NAKA-KU, HIROSHIMA CITY, HIROSHIMA 730-0032, JAPAN
TEL:+81-82-545-3680
(Main Number)
FAX:+81-82-243-4130
(Main Number)
E-Mail:


The trademark of HARAKENZO is based on a global map including lands each of which has a size corresponding to the number of patents registered in 1991.
Privacy policy

NEWS
IP News index

Otsuka Pharmaceutical Co. wins appeal hearing in ABILIFY® patent infringement case

On May 8, 2012, it was announced that Otsuka Pharmaceutical Co., Ltd. was victorious at the appeal hearing of a patent infringement case concerning ABILIFY®. Otsuka Pharmaceutical Co., Ltd had brought the case against a number of companies that had petitioned the FDA for permission to sell a generic form of ABILIFY®. As in the initial case, the CAFC confirmed the validity of the patent in question and on May 7, 2012 judged Otsuka Pharmaceutical Co., Ltd. the victor in the appeal.

http://www.otsuka.co.jp/company/release/2012/0508_02.html
































IP News index
PAGE TOP
Intellelution.com